J&J Unit Didn't Properly Serve Drug Patent Claim, US Says
The U.S. told a London court on Friday that a Johnson & Johnson pharmaceutical unit failed to properly serve a patent revocation claim over a blood cancer treatment, arguing that it...To view the full article, register now.
Already a subscriber? Click here to view full article